NASDAQ / Last 4 quarters

NVEC earnings call analysis

NVE Corporation. AI-assisted transcript summaries focused on management tone, evasions, goalpost moving, catalysts, risks, and data-center exposure.

4 storedJun 10, 2026

Research summary and source transcript

readyJun 10, 2026

NVE reported a 10% year-over-year revenue decline driven by an 11% drop in product sales, partially offset by a 17% increase in contract R&D revenue. Defense sales weakness was cited as the primary cause, with management noting procurement cycle variability. Non-defense sales stabilized and distributor sales improved, suggesting broader industry recovery. Gross margin declined to 81% from 86% due to a less profitable product mix and higher distributor sales, which carry lower margins. Despite lower revenue and margins, operating cash flow of $5.19 million covered the $4.84 million dividend, and the company advanced its multi-million dollar expansion with new wafer fabrication equipment deployment.

Management knows that the wafer-level chip scale sensor equipment cluster has been received and is being installed for deployment later in fiscal 2026, with samples and evaluation boards already being provided to customers in medical devices and industrial controls/robotics. They also know they are working with customers on near-term design wins for rare earth-free ferrite magnet systems, leveraging the abundance of iron and oxygen. The market likely will not see volume production from this equipment or confirm design win conversion to revenue for 6-24 months, as the company emphasizes sampling, evaluation, and capacity building rather than near-term sales.

Revenue is driven by product sales (particularly defense and distributor channels), contract R&D revenue, and gross margin influenced by product mix and sales channel mix (direct vs. distributor).

  • Wafer-level chip scale sensor development and deployment
  • Rare earth-free ferrite magnet opportunities and supply chain advantages
  • Defense sales variability due to procurement cycles
  • Distributor sales recovery and industry conditions
  • Capital equipment investment and tax credit benefits
  • Annual shareholder meeting and corporate governance
  • Detailed discussion of wafer-level chip scale sensors being less than a thousandth of a square inch and their spatial specificity advantages
  • Enthusiasm about ferrite magnets using abundant iron and oxygen versus China-dependent rare earth materials
  • Positive feedback from customers evaluating new sensor samples in medical and industrial markets
  • Optimism about design wins converting to near-term business for ferrite magnet systems
  • Satisfaction with the timing of equipment delivery ahead of tariff changes

Management presented information in a direct, factual, and credible manner, consistently grounding statements in observable actions such as equipment receipt, sample distribution, trade show participation, and customer engagement. They avoided overpromising, acknowledged uncertainties (e.g., defense timing, design win conversion), and provided specific details about technology (e.g., sensor size, material composition) without exaggeration. Their discussion of financials aligned with reported figures, and they distinguished between current capabilities (samples, evaluation) and future goals (volume production), enhancing credibility.

  • No clear dodged analyst question was detected by the local fallback; manual review should still check whether Q&A answers quantified conversion, margins, and guidance.
  • There may be a benchmark or metric-framing issue worth manual review, especially around adjusted metrics, timelines, or changed expectations.

The company appears to be maintaining its competitive position in niche spintronic sensor markets, particularly in defense (PUFs) and emerging opportunities in rare earth-free sensing. Management highlights unique advantages in sensor miniaturization and ferrite compatibility, but there is no evidence of market share gains or losses. The focus on sampling, design engagement, and IP development suggests a defensive to neutral competitive stance, relying on technology differentiation rather than scale or pricing power.

  • 10% year-over-year revenue decrease in Q1 FY2026
  • 11% decrease in product sales, partially offset by 17% increase in contract R&D revenue
  • Gross margin decreased to 81% from 86% due to less profitable product mix and strengthening distributor sales
  • Net income decreased 13% to $3.58 million ($0.74 per diluted share) from $4.1 million ($0.85 per share)
  • Operating cash flow was $5.19 million, covering the $4.84 million dividend
  • Fixed asset purchases were $1.06 million, mostly for a cluster of wafer fabrication equipment
  • Expect to realize $700K–$800K in advanced manufacturing investment tax credits in FY2026 if equipment deployed as planned
  • Deployment of wafer fabrication equipment cluster enabling future high-volume production of miniaturized sensors
  • Potential design wins in rare earth-free ferrite magnet systems as customers assess supply chain risks
  • Recovery in distributor sales indicating broader non-defense industry improvement
  • Advanced manufacturing investment tax credit yielding $700K–$800K in fiscal 2026
  • Section 179 tax changes allowing immediate expensing of previously unamortized R&D
  • Expectation of sequential growth in defense (PUF) business in coming quarters
  • Defense sales remain highly variable due to unpredictable procurement cycles
  • Gross margin pressure from lower-margin distributor sales and product mix shifts
  • Uncertain timing and conversion rate of design wins for wafer-level chip scale sensors into volume production
  • Dependence on successful installation and ramp-up of new wafer fabrication equipment for future capacity
  • No guarantee that ferrite magnet opportunities will materialize into significant revenue despite design activity
  • Reliance on contract R&D revenue to offset product sales weakness, which may not be sustainable

There is no direct or indirect evidence in the transcript of AI or data-center exposure. The company's discussions focus on spintronic sensors, medical devices, industrial controls, robotics, and defense applications (PUFs for anti-tamper systems). While spintronic MRAM is mentioned as long-term IP with potential for universal memory applications, management explicitly states they do not plan to scale up for large-scale memory due to the billions required for a memory fab, and their business model is limited to partnering with large-scale manufacturers for IP monetization. Any data-center relevance is speculative and not tied to current products or near-term plans.

  • What is the expected timeline for volume production of wafer-level chip scale sensors after equipment installation?
  • How many customers are currently evaluating the new ferrite magnet sensor systems, and what is the anticipated conversion rate to design wins?
  • What specific end-market revenue contribution does management expect from medical devices and industrial controls/robotics for the new miniaturized sensors in FY2026?
  • Can management provide a breakdown of R&D revenue by customer type or contract duration to assess its sustainability?
  • What is the utilization plan for the new wafer fabrication equipment between R&D and production, and what sales volume is required to justify the investment?
  • How does management assess the competitive landscape for ferrite-based sensing solutions, particularly regarding sensor sensitivity and system integration challenges?

FY2026 Q1 earnings call transcript

27,079 chars
NASDAQ:NVEC Q1 2026 Earnings Call Transcript Generated on 6/6/2026 Dan Baker | President and CEO: Good afternoon and welcome to the NVE Corporation conference call for the quarter ended June 30th, 2025. I'm Dan Baker, NVE's President and CEO. I'm joined as usual by Controller and Principal Financial Officer Daniel Nelson. This call is being webcast live via YouTube and Amazon Chime and being recorded. A replay will be available through our website NVE.com and our YouTube channel YouTube.com slash NVE Corporation. All participants are currently in listen-only mode. After our presentation, there will be a question-and-answer session. After my opening comments, Daniel Nelson will present our financial results, I'll cover the business, and then we'll open the call to questions. We issued our press release with financial results and filed our quarterly report on Form 10-Q in the past hour following the close of market. Links to the press release and the 10Q are available through our website, the SEC's website, and X, formerly known as Twitter. Please refer to the safe harbor statement on your screen. Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including, among others, such factors as uncertainties related to the economic environments and the industries we serve, risks and uncertainties related to future sales and revenue, and risks and uncertainties related to tariffs, customs, duties, and other trade barriers. as well as the risk factors listed from time to time in our filings with the SEC, including our annual report on Form 10-K for the year ended March 31, 2025. Actual results could differ materially from the information provided, and we undertake no obligation to update forward-looking statements we may make. We're pleased to report strong revenue and earnings for the quarter driven by an increase in distributor and non-defense sales, despite a decrease in defense sales. Daniel Nelson will cover details of the financials. Daniel? Daniel Nelson | Controller and Principal Financial Officer: Thanks Dan. The 10% year-over-year revenue decrease for the first quarter was due to an 11% decrease in product sales, partially offset by a 17% increase in contract R&D revenue. The decrease in product sales was due to a decrease in defense industry sales, which can be highly variable because of procurement cycles. We were pleased to see non-defense sales stabilize with improving industry conditions in the quarter. We saw an increase in distributor sales, which were hit particularly hard by the recent industry downturn. Gross margin decreased to 81% from 86% due to a less profitable product mix and strengthening distributor sales, which tend to have lower margins than direct sales. Total expenses decreased 20% for the first quarter of fiscal 2026 compared to the first quarter of fiscal 2025 due to an 18% decrease in R&D expense and a 23% decrease in SG&A. The decrease in R&D was due to completion of some of our wafer-level chip skill packaging activities and reallocation of some R&D resources to manufacturing. The decrease in SG&A was primarily due to the timing of sales and marketing activities and reallocation of some general and administrative resources to manufacturing. Net income for the first quarter of fiscal 2026 decreased 13% to $3.58 million, or $0.74 per diluted share, compared to $4.1 million, or $0.85 per share, for the prior year quarter. The decrease in net income for the first quarter of fiscal 2026 compared to the prior year was primarily due to decreased revenue and lower margins, partially offset by decreased expenses. Adding in approximately $75,000 in unrealized gains on our marketable securities, comprehensive income was $3.65 million. Our profitability metrics remain strong. Operating margin was 62%, pre-tax margin was 70%, and net margin was 59%. Fixed asset purchases were $1.06 million last quarter. Most of that was for a cluster of wafer fabrication equipment, which recently arrived. We were able to expedite the delivery to get the equipment before the U.S. reciprocal tariff pause was scheduled to expire July 9. We have a milestone payment of approximately $1 million due this quarter, which will substantially complete our two-year multi-million dollar expansion. Dan Baker will provide more color on capital investments in a few minutes. The 25% advanced manufacturing investment tax credit was extended in a recent tax bill. Therefore, we currently expect to realize advanced manufacturing investment tax credits of between $700,000 and $800,000 if we deploy equipment as planned in fiscal 2026. Although it would not significantly affect our earnings, we will also realize significant cash flow savings this fiscal year due to changes in Section 179 of the Internal Revenue Code. The recent legislation allows us to deduct on our tax returns previously unamortized R&D expenses rather than amortize them over five years. Turning to cash flow items, we paid our $1 per share quarterly dividend the past quarter and declared another dividend to be paid at the end of August. Operating cash flow was $5.19 million in the quarter, which more than cover our $4.84 million dividend. Accounts receivable decreased $1.34 million due to decreased revenue and the timing of customer payments. Accrued payroll and other liabilities increased $523,000, primarily due to the timing of estimated tax payments. Now I'll turn the call back over to Dan Baker to cover the business and preview our annual shareholders meeting. Back to you, Dan. Dan Baker | President and CEO: Thanks, Daniel. I'll cover CapEx, marketing, and our upcoming annual meeting. Starting with CapEx, we deployed one new machine in the past quarter. As Daniel Nelson mentioned, we also took possession of a several million dollar equipment cluster in the past quarter. It's being installed in an expanded production area on the east end of our building, and we hope to deploy it later this fiscal year. Turning to product development, in the past quarter we launched more wafer level chip scale sensors which are less than a thousandth of a square inch. There are demonstrations of new products on our website and our YouTube channel. We promoted new products including wafer level chip scale sensors and advanced magnetic switch sensors launched earlier in the year at two major trade shows the past quarter. The SensorPlus Test show was in Nuremberg, Germany, and the Sensors Converge show was in Silicon Valley. SensorPlus Test is billed as the leading international trade fair for sensor, measuring, and testing technology. And Sensors Converge is North America's largest electronics event. We've been following up on some good leads from the shows, and we believe the investments in these shows will pay off in future sales. We also promoted rare earth-free ferrite magnets and sensors to detect them. Most rare earth magnets and the materials to make them come from China, which has put the supplies at high risk. The primary ingredients of ferrite magnets, however, are iron and oxygen, the two most abundant elements in the earth's crust. Our unique high sensitivity magnetic switch sensors and angle sensors are ideal for use with readily available ferrite magnets. Videos of some of our recent demos are on our website and YouTube channel. Our annual shareholders meeting will be August 7th here at NVE. Our proxy statement for the meeting is available via our website or the SEC's website. Our meetings have been in person except during the pandemic, so shareholders can meet our managers and directors and see hands-on product demonstrations. If you can't make it in person, we plan to have a replay available. There are three agenda items for the annual meeting. The first agenda item is the election of directors. We're fortunate to have a strong independent board of directors, all of whom have extensive experience as directors or executives of public companies. The second agenda item is approval of our officer compensation. Our compensation principles as detailed in our proxy include we don't overpay our officers, our officers have the same fringe benefits as all employees, And there are no executive perks or golden parachutes. The third agenda item is the ratification of our auditors for this fiscal year, the year ending March 31, 2026. Boulay has been our auditor since 2019, and we recommend their approval for our next audit. We expect representatives from Boulay to attend the annual meeting. The proxy report's total shareholder return for the past three fiscal years was 39%, exceeding broad market returns. Our returns consisted of 17% stock appreciation and 22% from dividends. Now we'd like to open the call for questions. To ask a question from a phone, press star 7 to unmute, or from a browser or the Chime app, click the Raise My Hand icon under the meeting chat. That's at the bottom of the left column. And unmute yourself to speak. Please state your name and affiliation before your question. And to prevent background noise, please mute your line after asking your question. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Hi, Dan. It's Jeff Bernstein from Silverberg Bernstein Capital. Hi, Jeff. Hey, how are you? So, yeah, a couple of questions. You touched on the weakness in the puff business in the quarter, and it sounds like the distribution channel business is recovering. Can you give a little bit more color there? What do you think happens with the puff business in the next couple of quarters? Is there any kind of seasonality to that? Dan Baker | President and CEO: There's not really seasonality to the Puff business, but there is a certain amount of lumpiness to that business because it's driven by procurement contracts for defense systems. So those can be those can be they're typically large contracts, but they we don't know the exact timing. I should say for background, PUFs are physical unclonable functions, which is a function that's embodied in a physical structure that's easy to evaluate but hard to predict. So they're an important component of spintronic anti-tamper systems. And those systems are designed to protect sensitive data or electronics. So we sell those for military systems. They're often deployed in systems that are sold locally. to foreign militaries. And so there are some commitments that the DOD has for those types of systems. It helps us in the long run, but in the short run, it can be unpredictable. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: So Dan, it sounds like we should expect some growth with all the growth in in the DOD budget and defense budgets around the world that on a multi-quarter kind of basis, we ought to continue to look at this as a growth business. Dan Baker | President and CEO: Indeed. We currently expect that that business will grow quarter over quarter sequentially in the coming quarters, next quarter and the following quarters. And we expect to return to more historical levels in uh the next fiscal year um to the second part of your question though on distributor sales that's very encouraging because that's related to the strength of the industry as a whole and we're seeing the industry recover so to see those systems those sales increase i think bodes very well for the future okay and then you mentioned the this um Jeff Bernstein | Analyst, Silverberg Bernstein Capital: opportunity in replacing rare earth metals with ferrite magnets and your highly sensitive magnetic sensors. And I assume that is 100% for positioning kinds of measurements. The rare earth magnet business is a huge, huge business. The positioning part of that I think is a smaller but still a very large business nonetheless. I think a lot of automotive, but some other things as well. Can you just talk to us a little bit more about what you know and understand about that opportunity and how quickly you think design wins can convert to business, any kind of stumbling blocks there like availability of ferrite magnets, etc.? ? Dan Baker | President and CEO: Yeah, that's a good question, Jeff. And as you know, virtually all rare earth magnets and materials such as neodymium and disposium come from China. So that puts the supply chains at some risk. As far as the availability, as I mentioned in the prepared remarks, ferrite magnets are made from iron oxide, which is chemically similar to rust, and iron and oxygen are the two most abundant elements in the Earth's crust. So it's materials that are widely available. So we're continuously working with customers to help them design in magnetic systems. As you pointed out, often the magnetic system is a magnet in combination with a sensor. So you're detecting proximity such as whether a door is closed, a seat belt is latched, or something like that, or whether a robot has reached its desired position, a robot end effector or actuator. And we provide models for the entire system for our customers. So we're working with customers continuously, and our goal is to have near-term design wins. We also have engineering models on our So customers can go there and model a ferrite magnet and one of our sensors and move the magnet around to simulate the position of the magnet and the sensor and try different sensors and different magnets. So we're working to get design wins in the near term. And we do have design wins that have been customers who come to us and said they need this magnet combination often. a ferrite magnet, and we can provide them a solution. In some cases, we'll actually sell the magnet. We don't make a lot of revenue on magnets, but we sell them as a courtesy to our customers, or they can buy the magnet elsewhere. And particularly if it's a ferrite magnet, they're widely available. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Gotcha. So it sounds like this is somewhat interesting. normal kind of design cycle in terms of there would need to be a board spin to do this, but nothing more complicated than that. Dan Baker | President and CEO: Right. And in some cases, our customers have constraints, so they just need a magnet that drops in. So maybe they need a slightly bigger magnet if it's a ferrite magnet compared to a neodymium magnet, for example. But we can provide them solutions like that. that allow a minimum of redesign. And we're getting more inquiries, as you might expect, about ferrite magnets and more sensitive sensors than we were before when engineers might specify in a rare earth magnet. And now they're starting to think about the supply chain risk of those magnets and And we offer sensors that can detect the lower fields that one gets from a ferrite magnet. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Gotcha. And then I wanted to ask about the investment in the wafer scale packaging and trying to just understand how incremental revenue will correlate to that investment. Is this essentially giving you the opportunity to create much smaller parts because of the packaging and people get the sort of double whammy of knowing that the entire supply chain is now U.S. domestic or is it really the U.S. domestic supply chain that is the catalyst here? Just walk us through that and also, you know, do you have to have all the machines in place and up and running to take advantage of this, or are there some increments, and just how does that work? Dan Baker | President and CEO: Good questions. The short answer is it's both to make parts that are smaller. As I mentioned in the prepared remarks, some of these sensors are less than a thousandth of a square inch, so that means that they fit in tight spaces, and it also means that they have more spatial specificity, meaning that you can detect a magnetic field more precisely, as you can imagine, because the sensing area is smaller. The two main advantages, and we have much of the key equipment already deployed for wafer-level chip scale parts. We've been rolling out a variety of different types of parts. We promoted them at the two recent trade shows that I mentioned, SensorPlus Test in Germany and and sensors converge in Silicon Valley. And we're already providing samples and evaluation boards. We are working on developing high-volume production systems, and we'll be working on that in the next couple of quarters through this fiscal year to make sure that we have the capacity as our customers design in these parts. But right now, we can provide samples and pre-production quantities now, and we're doing that. Gotcha, understand. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: And then last question, you know, we talked a little bit during the quarter about, you know, discussion that normal SRAM is going to run out of gas at, I guess, below two nanometer kind of line width. And people are talking about the potential for spin orbit, torque RAM, SOT RAM is what they're calling it. You guys have some patents. I think it's called in your patent Vortex Spin Momentum Transfer Magneto Resistive Devices. And that's a patent issued back in 2011. But is that right? You know, at what point do you think this becomes something where there might be some relevant IP that you guys have? And how do you guys think about trying to capitalize on that? Dan Baker | President and CEO: Our company was founded and our original name was Non-Volatile Electronics, which refers to spintronic memory. And so it's important technology to us. We continue to develop the technology and we make and sell magnetic MRAM, spintronic magnetic MRAM or MRAM parts, mostly in anti-tamper applications to make crypto keys and and similar security applications where the density is relatively low, or the bit count. We don't plan to scale up for large-scale memory. It costs billions of dollars to make memory fab, so that's not part of our business plan, but we continue to develop our intellectual property. As you mentioned, we have intellectual property and patents on MRAM in general, as well as spin torque MRAM, as you alluded to, or spin momentum MRAM, as it's sometimes called. And our business model would be to partner with large scale manufacturers where appropriate to monetize our intellectual property and to help advance the technology. As you mentioned, SRAM and other types of memory run into scaling limitations that MRAM doesn't have. So we do see long-term opportunities there. The other advantage of spintronic memory or MRAM is that it has a combination of speed, non-volatility, and density that combines the best attributes of SRAM, DRAM, and FLASH or other non-volatile memories. So it's sometimes been called the universal memory. And when the density approaches that of conventional memories, it'll open up some excellent opportunities. And we're hoping to be able to provide intellectual property to help advance the technology. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Great. Thanks for the help today, Dan. Operator | Conference Call Moderator: Thanks, Jeff. Dan Baker | President and CEO: If there are other questions, star seven on a phone to unmute or raise my hand on a computer. Christopher Trotsky | Private Investor: Hello, this is Christopher Trotsky, private investor. Can you hear me? Dan Baker | President and CEO: Yes. Christopher Trotsky | Private Investor: Oh wow, that's a surprise. Okay, so about the chip level packaging, can you talk a little bit about what end markets that's going into and whether it's getting traction in that already? Dan Baker | President and CEO: For wafer-level chip scale parts, the end markets is what you're asking about, and we've identified two end markets. One is medical devices, where the miniaturization is important. Smaller medical devices, particularly implantable medical devices, result in smaller devices, less obtrusive, smaller incisions, and all of those benefits. The other market is industrial controls and robotics to allow more precise measurements Position sensing, as I mentioned in answer to a previous question, the parts are not only smaller, but they have more spatial specificity for more precision. So those are the two markets that we've identified, and we've sampled parts to customers in both markets. We don't have volume production yet. We have customers actively evaluating the parts, and so far the feedback has been quite positive. We're very optimistic about the prospects for these parts. Christopher Trotsky | Private Investor: But you're already selling devices into the implantable medical market. Would that be for next generation, or are you going into expanding into new implantable devices? Dan Baker | President and CEO: We are looking at new implantable devices. So, for example, navigation devices. So what that means in a medical sense is knowing the position of a small device such as a catheter that would be snaked into the body, and it's important to know the exact position. So these are very small catheters. They need a very small sensor that can detect a precise external magnetic field, The magnetic field helps navigate the catheter much as a magnetic compass helps us navigate on the earth. That's one example of a potential market where our devices currently, as small as they are, are not small enough for that market. And wafer-level chip-scale parts will be, we believe. Christopher Trotsky | Private Investor: Okay, that's good to hear. When you get those machines working, Will you consider production machines or NRE machines? My question really is if you do not get enough sales in those packages, is there a danger of looking at underutilization charges? Dan Baker | President and CEO: We plan to use the new machinery for both R&D and production. And we, despite the large investment compared to other semiconductor companies, we are relatively, we have a relatively low fixed costs and a relatively low amount of equipment for the revenue that we generate. So we, again, justified the equipment based on assumptions that we believe we can meet for increased and incremental sales, but also it's not the type of leverage that one might see in a commodity semiconductor market where if they don't keep the equipment busy, the fixed costs will damage their financials in many cases. we have less risk than that because of the relative low amount of fixed assets that we have for the revenue that we generate. And that's a tribute to the efficiency of our employees and the value of our technology. Christopher Trotsky | Private Investor: That is correct. We have much lower fixed assets than any other semiconductor company I've researched. And I guess another question I had is that lately, just looking at your YouTube channel, you're showing a lot of sensors for devices that use cylinders with like liquid force devices. I'm sorry, the word escaped me. Dan Baker | President and CEO: I think you're referring to cylinders, pneumatic cylinders. Yes. Yeah, you described it very well. Right. So they're using a fluid to push a piston to move something. And that's what a lot of our customers do. So that's what we show on We do have a lot of those on YouTube. Christopher Trotsky | Private Investor: Is that a new market? Because lately I've just been seeing those. Dan Baker | President and CEO: It's a legacy market for us, and we've had customers who make pneumatic cylinder positions or sensors for many years. but we're always finding new and creative uses for those, and our customers are as well. So the general category is linear actuators, and we are finding customers that want, I think some of the newer videos relate to more precise control that we can do with our newer types of sensors. So we have a new YouTube video, for example, that highlights one of our advanced magnetic switches that I mentioned in the prepared remarks that we introduced at the recent trade shows. And so that allows us to have more precise control of a pneumatic cylinder where we can slow it down at one threshold and then stop it at another. So just like, you know, just like if you're slowing down and stopping a car, you can stop it more precisely like that. And so that's an example of the type of demonstration that we have. We've had customers who've been using pneumatic cylinders for many years, but this opens up a new way of controlling them more precisely. We also have done some recent videos and demonstrations where some of our folks are very creative in coming up with ways of controlling linear position and familiar devices. We had a device that's playing a piano, moving an actuator around to a precise position and and then hitting the key. So there are some of those that we demonstrate as well to demonstrate the precision of our sensors, and in that case, the combination of the precision and the speed. Christopher Trotsky | Private Investor: Okay, that's good to hear that this market is expanding. And finally, I wanted to ask you, you know, for several quarters, we've seen that effect of military orders being very volatile today. Have you considered reporting revenue ex-military orders? For example, for this quarter, it would be very useful to tell that you have that ex-military orders, your revenue actually grew, which I think it did. Dan Baker | President and CEO: That's true. It did. And we will look at we look at that kind of continuously. Do we want to report a segment? The challenge with that is that to report it consistently, we need to have it audited and we need to break out not just the revenue, but the components of or the expenses and costs related to the revenue. So there's a fair amount of infrastructure that we need to do that. But we will look at that and we look at whether we should report certain segments. continuously. We're always looking at that. So we'll be looking also at defense spending. In the meantime, what we try to do is provide information to our investors, as we did on this call, to help understand what is behind our top and bottom line. Christopher Trotsky | Private Investor: Okay. That's good to hear. And the information you're providing is that military orders will actually sequentially increase this quarter and the next. Dan Baker | President and CEO: Is that correct? That's what we're expecting now. That's our current expectation, yes. Okay, this is it for me. Good luck. Thank you. Are there any other questions? Operator | Conference Call Moderator: Star 7 to unmute. Raise your hand on a computer. If there are no other questions, we were pleased to report strong revenue and earnings. Dan Baker | President and CEO: We continue to deploy new equipment and received a new equipment cluster. We look forward to speaking with you in October for our next quarterly call, and we look forward to seeing some of you August 7th at our annual meeting. A replay of this call will be available on the Investor Events page of our website, that's nve.com, and our YouTube channel, that's youtube.com slash nvecorporation. jsPDF 3.0.3 D:20260606090318-00'00'

Research summary and source transcript

readyJun 10, 2026

NVE reported a 3% year-over-year revenue increase in Q4 FY2025 driven by a 558% surge in contract R&D revenue and a 40% sequential increase in product sales, signaling stabilization after a weak first three quarters. Management emphasized new product launches, expanded R&D investment (14% of revenue), and planned CapEx of $2–3 million for FY2026 focused on wafer fabrication equipment to enable wafer-level chip scale production. While gross and net margins improved due to better product mix and direct sales, the business remains dependent on niche industrial and medical markets with no evidence of broad-based demand recovery.

Management knows today that the cluster of wafer fabrication equipment expected in the September quarter (Q1 FY2026) will enable in-house production of wafer-level chip scale sensors, a capability not yet reflected in current financials. This internal capability could unlock new product tiers and margin expansion over the next 6–24 months as production ramps and customer qualification progresses, but the market has not yet priced in the potential revenue or margin impact from this strategic shift in manufacturing.

Revenue is driven by product sales in medical devices and industrial IoT, contract R&D revenue, and gross margin expansion through favorable product mix and increased direct sales versus distributor channels.

  • Tariff risk mitigation and competitive advantage due to in-house fabrication and inventory buffers
  • Expansion of manufacturing capacity via new wafer fabrication equipment
  • R&D investment focus on next-generation sensors and MRAM for medical and anti-tamper applications
  • New product launches in omnidirectional magnetic sensors and high-voltage isolators
  • Customer engagement through trade shows and extension of key partnerships like Abbott Laboratories
  • Detailed emphasis on the technical superiority of new isolators, citing industry-leading 7 kV isolation voltage and common mode transient immunity (CMTI)
  • Enthusiastic description of new omnidirectional magnetic sensors enabling flexibility in industrial robotics and mechatronics
  • Strong emphasis on customer feedback for prototype wafer-level chip scale devices as basis for CapEx confidence
  • Pride in supplying 'some of the world's most demanding customers' and extending the Abbott partnership
  • Optimism that trade show investments will pay off in future sales despite near-term costs

Management displayed a direct and credible tone, providing specific technical details about product capabilities (e.g., 7 kV isolation voltage, CMTI) and concrete timelines for CapEx deployment. Claims were tempered with appropriate caveats such as 'while there are no guarantees' and 'we feel based on customer input.' There was no evident exaggeration or promotional language; instead, excitement was grounded in customer feedback and technical milestones, supporting a perception of honesty and operational focus.

  • No clear dodged analyst question was detected by the local fallback; manual review should still check whether Q&A answers quantified conversion, margins, and guidance.
  • No clear goalpost move was detected by the local fallback; the main follow-up is whether future quarters keep the same KPIs and conversion targets.

NVE appears to be maintaining or strengthening its competitive position in niche markets for high-performance magnetic sensors and isolators, particularly in medical and industrial applications, based on claims of industry-leading technical specifications and customer validation. However, without comparative data or market share metrics, it is not possible to determine whether the company is gaining or losing ground relative to peers. The investments in R&D and CapEx suggest an effort to extend its technological lead, but competitive positioning remains not fully assessable from the transcript alone.

  • 3% year-over-year revenue increase in Q4 FY2025
  • 558% increase in contract R&D revenue year-over-year in Q4 FY2025 ($270,000 absolute increase)
  • 44% sequential revenue growth in Q4 FY2025 driven by 40% increase in product sales and 210% increase in contract R&D
  • Gross margin increased to 79% in Q4 FY2025 from 76% in prior year quarter
  • Fiscal year 2025 gross margin increased to 84% from 77% in fiscal year 2024
  • Planned CapEx of $2–3 million for fiscal year 2026, up from $1.2 million in fiscal year 2025
  • R&D expense increased 28% in Q4 FY2025 and 33% for the fiscal year, totaling 14% of revenue for the year
  • Net income increased 2% year-over-year in Q4 FY2025 to $3.89 million ($0.80 per diluted share)
  • Installation and ramp of new wafer fabrication equipment cluster in Q1 FY2026 enabling in-house wafer-level chip scale production
  • Potential revenue contribution from new high-sensitivity and omnidirectional sensor products in medical and industrial markets
  • Possible margin expansion from increased direct sales and shift to higher-value wafer-level packaging
  • Qualification of new products with key customers like Abbott Laboratories leading to broader adoption
  • Successful demonstration and customer interest in next-generation MRAM and TMR sensor initiatives
  • Revenue growth remains dependent on volatile industrial and medical device end markets with no signs of broad recovery
  • High R&D and CapEx spending may not translate into proportional revenue growth if new products fail to gain traction
  • Gross margin improvement is tied to product mix and channel shift, which may not be sustainable
  • Concentration risk in key customers such as Abbott Laboratories, though not quantified
  • Inventory buildup, particularly in work-in-process ($968,000 increase), could signal overproduction or weakening demand if not absorbed

There is no evidence in the transcript of direct or indirect exposure to AI or data center demand. NVE's products are focused on medical devices, industrial control, and IoT applications, with no mention of servers, networking, or data center-related use cases. The company's isolators and sensors are positioned for high-voltage industrial and medical systems, not data center power or signal conditioning. Any potential benefit from broader electrification trends is speculative and not supported by management commentary.

  • What is the expected timeline for revenue contribution from the new wafer fabrication equipment cluster?
  • What specific customers or end markets are expected to adopt the wafer-level chip scale sensor products?
  • What is the gross margin profile expected for wafer-level chip scale parts versus current product lines?
  • How much of the R&D spend is allocated to customer-funded versus internal new product development?
  • What is the inventory turnover trend for work-in-process, and is the $968,000 increase aligned with expected production ramps?
  • What percentage of revenue is now derived from direct sales versus distributor channels, and is this shift sustainable?

FY2025 Q4 earnings call transcript

17,740 chars
NASDAQ:NVEC Q4 2025 Earnings Call Transcript Generated on 6/6/2026 Dan Baker | President and CEO: Good afternoon and welcome to the NVE Corporation conference call for the quarter and fiscal year ended March 31st, 2025. I'm Dan Baker, NVE's President and CEO. I'm joined as usual by Controller and Principal Financial Officer Daniel Nelson. This call is being webcast live via YouTube and Amazon Chime and being recorded. A replay will be available through our website, NVE.com, and our YouTube channel, YouTube.com slash NVE Corporation. All participants are currently in a listen-only mode. After our presentation, there will be a question and answer session. After my opening comments, Daniel Nelson will present our financial results. I'll cover tariffs, manufacturing, R&D, and sales and marketing, and then we'll open the call to questions. We issued our press release with financial results and filed our annual report on Form 10-K in the past hour following the close of market. Links to the press release and the 10-K are available through our website, the SEC's website, and X, formerly known as Twitter. Please refer to the Safe Harbor Statement on your screen. Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including, among others, such factors as uncertainties related to the economic environments and the industries we serve, risks and uncertainties related to future sales and revenue, and risks and uncertainties related to tariffs, customs, duties, and other trade barriers, as well as the risk factors listed from time to time in our filings with the SEC including our just filed annual report on Form 10-K. Actual results could differ materially from the information provided and we undertake no obligation to update forward-looking statements we may make. We're pleased to report a 3% year-over-year increase in revenue and 44% sequential revenue growth for the quarter and a 2% increase in earnings as industry conditions improve. Daniel Nelson will cover details of the financials. Daniel? Daniel Nelson | Controller and Principal Financial Officer: Thanks, Dan. The 3% year-over-year revenue increase for the fourth quarter was due to a $270,000 or 558% increase in contract R&D revenue, partially offset by a 1% decrease in product sales. Sequentially, total revenue increased 44% from the immediately prior quarter, driven by a 40% increase in product sales and a 210% increase in contract R&D. We are pleased to see revenue stabilize with improving industry conditions in the quarter. We are also seeing interest in our new products. Gross margin increased to 79% from 76% due to a more profitable product mix and a larger portion of direct rather than distributor sales. Total expenses increased 17% for the fourth quarter of fiscal 2025 compared to the fourth quarter of fiscal 2024 due to a 28% increase in R&D partially offset by a 2% decrease in SG&A. The increase in R&D expense was primarily due to an increase in new product development. Net income for the fourth quarter of fiscal 2025 increased 2% to $3.89 million, or $0.80 per diluted share, compared to $3.81 million, or $0.79 per diluted share, for the prior year quarter. The increase in net income for the fourth quarter of fiscal 2025 compared to the prior year quarter was primarily due to increased revenue and higher margins, partially offset by increased expenses. Our profitability metrics remain strong. Operating margin was 58%, pre-tax margin was 65%, and net margin was 54% for the quarter. For the fiscal year, revenue decreased 13% due to decreases in the first three quarters of the fiscal year, partially offset by the increase in the most recent quarter. Gross margin increased to 84% for fiscal 2025 from 77% for fiscal 2024 due to a more profitable product mix and a larger portion of direct rather than distributor sales. Total expenses increased 25% for the year due to a 33% increase in R&D and a 13% increase in SG&A, primarily due to increased new product development and increased sales and marketing. We believe these investments will pay off in the future with higher revenues. Non-operating income for the fiscal year includes interest and other income. Interest for the year decreased 2% due to decreased in marketable securities, partially offset by higher bond yields in the past year. We also reported other income of $135,000 for the fiscal year, primarily from reclaiming precious metals used in our manufacturing process. Net income was down 12% to $15.1 million in a tough industry environment, but still a solid $3.12 per share. Adding in approximately $700,000 in unrealized gains on marketable securities, comprehensive income for the year was $15.8 million. Operating margin was 62%, pre-tax margin was 70%, and net margin was 58% for the year. Fixed asset purchases were $1.2 million last fiscal year, which is unusually large for us. We are planning even more this fiscal year, $2 to $3 million in capital investments for fiscal 2026. The biggest chunk of that investment is for a cluster of wafer fabrication equipment, which we expect to receive next quarter, the September quarter. Then Baker will provide color on capital investments in a few minutes. Turn into cash flows. Accounts receivable increased $444,000 during fiscal 2025 due to increased revenue in the fourth quarter and the timing of customer payments. Inventories increased $291,000 in the year. Working process inventories increased by a significant $968,000. Working process inventories generally have the flexibility to make different products depending on market demands. As we've said before, we believe inventories provide a buffer against supply disruptions and other disruptions such as tariffs. We paid our $1 per share quarterly dividend the past quarter and declared another dividend to be paid at the end of this month. We have now paid over $200 million, more than $42 per share, in dividends since we started paying dividends 10 years ago. Now I'll turn the call back to Dan Baker to cover the business. Back to you, Dan. Dan Baker | President and CEO: Thanks, Daniel. I'll cover tariffs, manufacturing, R&D, and sales and marketing. We've identified three major risks related to tariffs. The first risk is that tariffs trigger global recession or industry downturn, which probably isn't good for anybody. Other than those broad-based macroeconomic concerns, however, we're uniquely well-situated with respect to tariffs. The second risk is tariffs on imported raw materials. This represents a relatively small portion of our costs since we do Spintronics fabrication in-house. We have been paying 25% tariffs on raw material imports from China since 2018, and it has not been significant. Most of what we purchase from China has not been subject to the recent so-called reciprocal tariffs imposed by the United States, since there is an exception for semiconductors. Furthermore, as Daniel noted, we have ample raw material and work-in-process inventories. The third risk is that our exported parts would be subject to another country's retaliatory tariffs. Fortunately, other countries such as China exempt semiconductor products such as ours. Furthermore, China classifies country of origin based on foundry wafers, which we source primarily from outside the United States. Therefore, the great majority of our exports to China are exempt from retaliatory tariffs. Most countries other than China classify country of origin based on the packaging location, which is also outside the United States for us. So the great majority of exports to other countries would not be subject to retaliatory tariffs. We have discussed plans to offer some parts as wafer-level chip scale parts with final processing here. We believe those wafer-level chip-scale parts could be subject to some retaliatory tariffs, but most of the potential business we've identified is in the United States. Our unique tariff situation and ample inventories could provide competitive opportunities compared to other U.S.-based companies with more tariff exposure. Turning to manufacturing, we're continuing our plans to expand our capacity and capabilities. We completed our planned expansion in the past quarter, including construction work, and recently completed electrical and other infrastructure upgrades to support new equipment. We deployed one new machine in the past fiscal year, we just deployed another machine this quarter, and a several million dollar machine is scheduled to arrive next quarter, the September quarter. Turning to customers, we're proud to supply products to some of the world's most demanding customers, including Abbott Laboratories. Abbott is a leading supplier of implantable medical devices. In the past quarter, we executed an extension of our supplier partnering agreement with Abbott. The agreement was filed with a Form 8K and is available via our website or the SEC's website. Turning to marketing, we're exhibiting at two major trade shows this quarter. The SensorPlus test show is underway now in Nuremberg, Germany. It's billed as the leading international trade fair for sensor measuring and testing technology. We will also be at SensorConverge in Silicon Valley in late June. That show is billed as North America's largest electronics event. We have several new products and new demonstrations at this year's shows. We believe the investments in these shows will pay off in future sales. We had an excellent quarter and fiscal year for product development. As Daniel mentioned, we've significantly increased our investment in R&D. We spent 14% of revenue in the past year on R&D. Additionally, we do customer-sponsored R&D, which is included in cost of sales. In the past quarter, we launched the world's most advanced magnetic switch sensors with more reliable data, more information, and rugged operation. There are several demonstrations of the new products on our website and our YouTube channel. In the fiscal year, we introduced a new high-sensitivity ultra-miniature sensor, a high-sensitivity rotation sensor, our first wafer-level chip scale sensors, a number of new evaluation and breakout boards. and the advanced position sensors I discussed earlier. We also invested in advanced R&D initiatives with the potential to drive future growth, including next-generation MRAM for anti-tamper applications, next-generation sensors for hearing aids and medical devices, extremely sensitive TMR sensors, and more wafer-level chip scale sensors. Now we'd like to open the call for questions. To ask a question, from a phone, press star 7 to unmute, or from a browser or the Chime app, click the Raise My Hand icon under the Meeting Chat. That's at the bottom of the left column, and unmute yourself to speak. Please state your name and affiliation before your question. And to prevent background noise, please mute your line after asking your question. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Hey, Dan, it's Jeff Bernstein from Silverberg Bernstein Capital. Dan Baker | President and CEO: Hi, Jeff. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Hi, Dan and Ann. So, yeah, a couple of questions here. You know, last quarter revenue was somewhat disappointing. We were talking about potentially being near the end of liquidation of inventory by customers in the distribution channel. Obviously, a strong snapback here in the quarter. And at the same time, you guys have been investing aggressively in R&D and in CapEx in a way that you haven't really in the past. So can you just parse for us how much of this quarter's improvement in revenue was the result of a snapback in the channel, some channel sale or people being a little bit more aggressive on ordering in line with their consumption? versus, you know, new business. Dan Baker | President and CEO: It was a combination of both. We saw inventories continuing to be bled down, which is a positive sign. So customers are replenishing and buying more for their end use. And also we've seen new business and significant interest in our new products. So we think that that all bodes well, and we were pleased that it was high quality revenues for the past quarter. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: Okay. And then can you just talk a little bit about the new parts that you introduced this year in terms of their expansion of your TAM, you know, what end markets or capabilities are they enabling? Dan Baker | President and CEO: Our new products are focused on markets where we have traditional strength. Those are medical devices and industrial control and the industrial internet of things. So the products that we introduced most recently were advanced magnetic sensors that are so-called omnidirectional, meaning that they can sense magnetic fields in any direction. So that provides tremendous flexibility for industrial controls for advanced robotics. And they provide much higher quality data from the mechatronics. So we've seen significant interest in those products. And then the other products tend to focus on markets where we're strong and we increase our advantages in terms of size and sensitivity so our our strategy is to lead the industry in terms of the performance the accuracy the size and the power consumption and efficiency of sensors gotcha and and then i'm just curious on the um isolator Jeff Bernstein | Analyst, Silverberg Bernstein Capital: You know, there's some new solid state technology to be used in very high voltage systems that replace mechanical switches and things. And I'm just curious as to, you know, how high voltage environments can your isolators work in? Dan Baker | President and CEO: Well, that's a great point. So what Jeff is referring to are what are so-called wide band gap FETs or transistors. which can switch higher voltages with less losses. So we provide interfaces, our isolators provide interfaces between the controller systems and those switches, because you can't directly hook them up to microcontrollers. And our devices have the highest isolation voltage in the industry up to seven kilovolts, which is truly remarkable. And that allows us to interface to some of those higher voltage switches where other isolators would fail. The other figure of merit that we have best in the industry is what's called the common mode transit immunity, which is the rate of change of the voltage. So that's rated typically in kilovolts per microsecond. And our devices have by far the highest CMTI or common mode transient immunity in the industry. So again, that helps to allow much faster switching at higher voltages, which allows customers to harness the advantages of those new wide band gap transistors. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: That's great. And then last, Dan, just so I think in the 10K, you're usually very pithy 10K. It does say that you're planning CapEx in 2026 of $2 to $3 million. That would be significantly above the $1.3 million spend in 2025, which also I think was a record. Unknown: Hey, hey, hey. Hey, hey, hey. Okay. Okay. Okay. Dan Baker | President and CEO: Well, I think Jeff might have had some audio difficulties there, but he was asking about CapEx. So as Jeff pointed out in the premise of his question, we're planning significant capital expenditures this fiscal year, which is the fiscal year ending March 31st, 2026. um after um already making significant investments in the past fiscal year so those will allow us to increase our capability increase our capacity and give us the possibility of making more wafer level chip scale parts in-house the um so uh those plans are proceeding and as daniel and i both mentioned in our prepared remarks One of the major investments is a cluster of equipment that we expect in the September quarter, next quarter, the quarter following this quarter. And we're already prepared with the construction and the infrastructure for that equipment, and we'll be working to install it and get it running as quickly as possible. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: So, Dan, before I lost you, I was asking, you know, what kind of gives you the confidence, you know, that you're going to earn a return on this CapEx investment? Dan Baker | President and CEO: So, yeah, as you know, Jeff, we look pretty carefully at getting a return when we spend our shareholders' money as we as we are planning to do with this equipment. And the confidence that we have is that we've made prototype and sample devices and the customer feedback has been excellent on those devices. And we feel based on the customer input that while there are no guarantees, we're very optimistic that this is going to open significant new markets for us. Jeff Bernstein | Analyst, Silverberg Bernstein Capital: That's great. Thanks for the questions. Dan Baker | President and CEO: Thanks, Jeff. Are there any other questions? If so, from a phone, press star seven to unmute or click raise my hand from the web. If there are no other questions to sum up, we were pleased to report increased revenue and earnings for the quarter year over year and strong quarter over quarter revenue growth. We had an exceptional year for product development and completed a significant expansion the past quarter and deployed new equipment in the past fiscal year. We look forward to speaking with you again in July for our first quarter fiscal 2026 earnings call. A replay of this call will be available on the investor events page of our website, nve.com, and our YouTube channel. That's youtube.com slash nvecorporation. jsPDF 3.0.3 D:20260606090319-00'00'

Research summary and source transcript

readyJun 10, 2026

NVE Corporation reported a 25% year-over-year revenue decline in Q3 FY2025 driven by weak product sales and completed contract R&D, yet maintained strong profitability with 84% gross margin and 60% net margin due to a favorable product mix shift toward higher-margin direct sales. Management emphasized ongoing R&D investment (17% of revenue), new wafer-level chip-scale product launches, and capacity expansion via leased facility upgrades and equipment purchases, signaling a focus on long-term positioning despite near-term demand weakness.

Management knows today that the company has successfully transitioned a meaningful portion of its sales to direct channels, which avoids distributor discounts and underpins the exceptional gross and net margins observed despite declining revenue. This structural shift in sales mix—confirmed by Daniel Nelson’s attribution of margin expansion to 'more profitable product mix and a larger portion of direct rather than distributor sales'—is not yet fully reflected in market perceptions, which may still weigh the company primarily on top-line trends. The sustainability of this mix shift and its durability through a potential industry recovery represent material information the market may not fully appreciate for 6-24 months.

Revenue is driven by product sales (particularly direct sales of spintronic sensors) and contract R&D; profitability is driven by gross margin expansion via favorable product mix and channel shift; long-term value is driven by R&D-led new product introduction (e.g., wafer-level chip scale sensors) and capacity expansion to support high-volume manufacturing.

  • R&D investment and new product development (wafer-level chip scale sensors)
  • Shift toward direct sales and its impact on margins
  • Capacity expansion via leased facility upgrades and equipment procurement
  • Optimism about end-market recovery in medical, defense, and industrial sectors
  • Role of sensors in enabling AI and advanced algorithms via data input
  • Detailed discussion of wafer-level chip scale products as 'world's smallest' enabling smaller medical devices and precise robotics
  • Enthusiasm about evaluation board platform integrating with Arduino and its role in customer adoption
  • Optimism about AI-driven demand for sensor inputs in hearing aids and medical devices
  • Confidence in long-term defense ('puff') business despite quarterly lumpiness
  • Pride in lease extension and facility expansion progress, including completed construction and upcoming infrastructure upgrades

Management exhibited a candid and credible tone, acknowledging persistent industry challenges while providing specific, evidence-based explanations for financial results—such as attributing margin expansion to direct sales mix and R&D increases to new product development. They avoided overpromising, tempering optimism about market recovery with realism about timing ('taking longer than anyone would like'), and grounded excitement in tangible progress (e.g., product launches, lease execution, equipment deployment). Their willingness to discuss both strengths (margins, R&D) and weaknesses (revenue decline, channel inventory) supports credibility.

  • No clear dodged analyst question was detected by the local fallback; manual review should still check whether Q&A answers quantified conversion, margins, and guidance.
  • No clear goalpost move was detected by the local fallback; the main follow-up is whether future quarters keep the same KPIs and conversion targets.

NVE appears to be maintaining or strengthening its competitive position in high-performance spintronic sensors, particularly in precision-dependent applications like medical devices and defense, where its technology’s advantages in size, power efficiency, and magnetic field sensitivity are valued. Management’s emphasis on displacing Hall sensors and GMR’s legacy strength suggests confidence in technical differentiation. However, without data on market share, customer wins, or competitive pricing pressure, a definitive assessment of gaining or losing ground cannot be made from the transcript alone.

  • Q3 FY2025 revenue: down 25% YoY (22% product sales decline, 74% contract R&D decline)
  • Q3 FY2025 gross margin: 84% (up from 80% YoY)
  • Q3 FY2025 operating margin: 58%, net margin: 60%, EPS: $0.63
  • R&D expense: 17% of revenue in Q3 FY2025
  • CapEx: $1.16 million spent through three quarters of FY2025 toward $4–5M two-year plan
  • Lease extension: 62 months through May 2031 with $100,000 improvement allowance
  • Recovery in end-market demand (medical, industrial, defense) leading to improved product sales
  • Successful ramp of new wafer-level chip scale products into volume production
  • Completion of facility expansion and infrastructure upgrades enabling higher capacity
  • Growth in AI-enabled end applications (hearing aids, medical devices) increasing sensor TAM
  • Conversion of evaluation board engagement into design wins and subsequent orders
  • Continued weakness in distributor channels due to inventory gluts and weak chip demand
  • Lumpiness and unpredictability in contract R&D and defense ('puff') sales
  • Risk that new product investments do not translate into sustained volume or market adoption
  • Dependence on niche end markets (medical, defense) with long sales cycles and regulatory hurdles
  • Potential margin pressure if direct sales mix cannot be maintained or expanded

There is no direct evidence in the transcript of NVE Corporation’s products being used in data center applications. Management discussed sensor applications in hearing aids, medical devices, robotics, and defense, emphasizing their role in providing data inputs for AI algorithms and enabling smaller, more efficient devices. While spintronic sensors could theoretically support edge computing or AIoT devices that interface with data centers, no explicit link to data center infrastructure, servers, or AI training/inference workloads was made. Any data center impact remains speculative and indirect, contingent on broader AI adoption trends increasing demand for sensor inputs in connected devices.

  • What percentage of total revenue came from direct sales in Q3 FY2025, and how has this mix trended over the past 4 quarters?
  • What is the expected timeline for volume production ramp of the new wafer-level chip scale products, and what capacity constraints, if any, exist?
  • How much of the $100,000 lease improvement allowance has been allocated, and what specific equipment or infrastructure is being funded?
  • What is the win rate or conversion metric from evaluation board engagements to design wins or purchase orders?
  • Beyond hearing aids, what specific AI-enabled end markets (e.g., industrial IoT, robotics, automotive) are showing the strongest traction for sensor adoption?
  • How sustainable is the current 60% net margin level if product sales recover but distributor channel sales rebound?

FY2025 Q3 earnings call transcript

16,159 chars
NASDAQ:NVEC Q3 2025 Earnings Call Transcript Generated on 6/6/2026 Dan Baker | President and CEO: Good afternoon and welcome to the NV Corporation conference call for the quarter ended December 31st, 2024. I'm Dan Baker, NV's President and CEO. I'm joined by Controller and Principal Financial Officer Daniel Nelson. This call is being webcast live via YouTube and Amazon Chime, and it's being recorded. A replay will be available through our website, nve.com, and our YouTube channel, youtube.com slash nvecorporation. All participants are currently in listen-only mode. After our presentation, there will be a question-and-answer session. After my opening comments, Daniel Nelson will present our financial results. I'll cover R&D, sales and marketing, and CapEx, and we'll open the call to questions. We issued our press release with financial results and filed our quarterly report on Form 10-Q in the past hour following the close of market. Links to the press release and 10-Q are available through the SEC's website, our website, and on X, formerly known as Twitter. Please refer to the Safe Harbor Statement on your screen. Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including among others such factors as uncertainties related to the economic environments and the industries we serve, and risks and uncertainties related to future sales and revenue. as well as the risk factors listed from time to time in our filings with the SEC, including our annual report on Form 10-K for the year ended March 31, 2024. Actual results could differ materially from the information provided, and we undertake no obligation to update forward-looking statements we may make. We're pleased to report strong earnings despite continued challenges in the semiconductor industry. Daniel Nelson will cover the financials. Daniel? Daniel Nelson | Controller and Principal Financial Officer: Thanks, Dan. Total revenue for the quarter ended December 31, 2024 decreased 25% compared to the quarter ended December 31, 2023 due to a 22% decrease in product sales and a 74% decrease in contract research and development revenue. The decrease in product sales was due to continued inventory gluts, particularly in the distributor channels, driven by weak chip demand and a slow recovery in industry sectors and markets we serve. The decrease in contract R&D revenue was due to the completion of certain contracts. Gross margin for the quarter was 84% compared to 80% the prior year quarter. The increase in gross margin percentage was due to more profitable product mix and a larger portion of direct rather than distributor sales. Total expenses increased 40% for the third quarter of fiscal 2025 compared to the third quarter of fiscal 2024 due to a 61% increase in R&D and a 12% increase in SG&A. The increase in R&D was due to increased investments in new product development activities. The increase in SG&A was primarily due to increased sales and marketing activities and additional sales staff in the past quarter. Interest income for the third quarter of fiscal 2025 decreased 4% due to a decrease in marketable securities and lower yields on recently purchased marketable securities. In addition to operating income, we reported other income in the third quarter of fiscal 2025 of $135,000, primarily from the reclaiming of precious metals used in our manufacturing process. Net income for the quarter decreased 27% with a decrease in revenue. It was a profitable quarter with 84% gross margin, 58% operating margin, 60% net margin, and earnings of 63 cents per share. For the first nine months of fiscal 2025, total revenue decreased 18% due to a 20% decrease in product sales, partially offset by a 72% increase in contract R&D. Net income for the first nine months was $11.2 million, or $2.31 per diluted share. For the fiscal year to date, gross margin was 85%, operating margin was 63%, and net margin was 60%. Now I will turn the call back to Dan Baker to cover the business. Back to you, Dan. Dan Baker | President and CEO: Thanks, Daniel. I'll cover R&D, sales and marketing, and CapEx. As Daniel mentioned, we've significantly increased our investment in R&D. We spent 17% of revenue in the past quarter on R&D. Additionally, we do customer-sponsored R&D, which is included in the cost of sales. As a result of the efforts of our R&D team, we introduced new wafer-level chip scale products in the past quarter. The new products are billed as the world's smallest devices of their type, which allows for smaller, less obtrusive medical devices, and more precise robotics and mechatronics. Our YouTube channel has a demonstration. A key element of our sales and marketing strategy is evaluation boards. Evaluation boards allow customers to easily visualize, create, and implement great new designs with our unique products. A new evaluation platform connects to the popular Arduino line of single board computers and uses one of a dozen angle or rotation sensor breakout boards. There's more information on our website and our YouTube channel has a demonstration of the new platform. Turning to CapEx. We've previously discussed plans for $4 to $5 million in capital investments over the next two fiscal years, fiscal 2025 and 2026. We've already spent $1.16 million through three quarters of this fiscal year, fiscal 2025. We deployed one new machine in the second quarter. We're working on another new machine now. and we'll have a several million dollar machine scheduled to arrive next quarter, the June quarter. In the past quarter, we reached an agreement to extend our building lease an additional 62 months through May 2031. The agreement also includes a $100,000 improvement allowance. We believe the allowance will cover our expansion. We filed the amendment to the lease agreement with the SEC. Links to the amendment are available on our website and the SEC's website. Construction work for expansion began in November, shortly after we agreed to the lease extension, and was completed last week. Next up is a new electrical service and other infrastructure upgrades to support new equipment. The investments in facilities and equipment will increase our capacity and capabilities, including the capability to manufacture wafer-level chip scale parts, such as the ones we recently introduced, in high volume. Now we'd like to open the call for questions. To ask a question from a phone, press star seven to unmute, or from a browser or chime app, click the raise my hand icon under the meeting chat that's at the bottom of the left column and unmute yourself to speak. Please state your name and affiliation before your question. To prevent background noise, please mute your line after asking your question. Jeff Bernstein | Analyst: Hey, Dan, it's Jeff Bernstein. Dan Baker | President and CEO: Hi, Jeff. Jeff Bernstein | Analyst: How are you? A couple questions here. Just give us a little better feeling about what's going on in direct business. You talked about inventory liquidation continuing in distribution. What are you seeing in terms of orders fulfilled in the quarter, turns kind of business, any other feel for how the demand is at end customers. Dan Baker | President and CEO: That's a good question, Jeff. Our direct sales have held up relatively well. Those customers tend not to buy through distribution, and as Daniel mentioned in the prepared remarks, there's a lot of inventory in the distribution channel that needs to be burned off. So those sales, those direct sales, tend to be higher margins because we don't have distributor discounts in the middle. And so that's the reason that our margins are so exceptional and our profitability metrics, despite the downturn in the revenue, are quite strong. Jeff Bernstein | Analyst: Gotcha. Any color you can put around how bookings have been going with those direct customers or anything around your book and ship kind of business? Dan Baker | President and CEO: In general, the outlook has been positive. When we talk to our customers, when we even talk to our distributors, they see things improving. They see industry conditions improving. It's taking longer than anyone would like, but we're very optimistic about the future and the fundamentals of our business are strong. Jeff Bernstein | Analyst: Gotcha. And so do you get the sense that consumption is actually above what you're selling into the channel now? Dan Baker | President and CEO: uh yes uh almost certainly uh because the distributors uh in the channel are trying to bleed down their inventories so they're selling but they're often not buying until their inventories are back to historical levels gotcha okay and then just a couple questions on on end markets um so both sunova and starkey that you know big traditional Jeff Bernstein | Analyst: hearing aid players are out with new platforms that incorporate real-time AI chips, et cetera. Seem like they probably draw a lot of power in what's a very tiny package. Can you just remind us the offerings that you have that go into, potentially go into hearing aids and what your thoughts are around your TAM development there? Dan Baker | President and CEO: We provide sensors, so as you mentioned, Sonofa, for example, has introduced a platform with artificial intelligence, and the technology helps the so-called speech and noise problem, which is a significant problem for hearing aids. So it's a great development and hopefully will improve uptake of hearing aids as they can help more people. NDE sensors provide inputs for artificial intelligence. Better information about the environment means better results from AI. So we're optimistic about those trends, about the need for more inputs and richer data to feed these artificial intelligence and other increasingly sophisticated algorithms. Jeff Bernstein | Analyst: Okay. And then the puff business has been a source of volatility for you guys. I think it was stronger last quarter. What's happening? What happened there this quarter? Dan Baker | President and CEO: So those those sales, as you know, can be lumpy and very quarter to quarter based on procurement schedules. But that business has been strong. It's a relatively small part of our business, but we received some orders recently spread out through the future. But we're certainly optimistic about long term defense sales based on what we see now. Jeff Bernstein | Analyst: Gotcha. And And just Abbott reported today it looked like all of the product areas that you might play in were reasonably strong, and obviously they have some exciting new products there. Any color on just the medical device business overall? Dan Baker | President and CEO: As you can imagine, we also look at Abbott's reports and we communicate with them. They reported decent growth, 6% overall growth in rhythm management, which is an area that we participate in. That's encouraging. And they've reported that that's more than the overall growth in the cardiac rhythm management market. As far as the specifics, we're bound by confidentiality, but our technology enables smaller devices, which is important for leadless pacemakers and other emerging technology. And we can detect extremely small magnetic fields, which is another key advantage for deeply implanted medical devices. So it's an area where we see considerable future potential. Jeff Bernstein | Analyst: All right. Thanks very much, Dan. Dan Baker | President and CEO: Thank you, Jeff. Pete Previtt | Shareholder: Hey, Dan. This is Pete Previtt from Florida. I met you at the shareholders meeting. How are you? Dan Baker | President and CEO: Yes. Good to talk to you, Pete. We might be warmer than you are. Pete Previtt | Shareholder: it's very rare dan but that's probably the case i had a couple questions actually jeff um mentioned something about ai chips and i was wondering um with with your mtj parts are are they i know you're focused on sensors but um mtj does that have potential to be part of uh ai chips and for energy reduction you know power consumption reduction Dan Baker | President and CEO: Yeah, so, uh, stands for magnetic tunnel junction and it's 1 of the core platform technologies that we have and it, uh, it's useful in a number of areas. Sensors is certainly 1 also useful in memory and we make. memory and memory-related devices for the defense business and the puff business that Jeff alluded to in his comments. Yes, they're low power, which allows for ubiquitous sensing, and much as the possibilities for artificial intelligence for medical devices for hearing aids, artificial intelligence and the artificial intelligence of things is driven by data. So the intelligence is only as good as the data that comes into it, and sensors provide that data. So while we don't directly make artificial intelligence processors, we participate in that revolution by providing the information that feeds the intelligence of the AI engines. Pete Previtt | Shareholder: Great. Thank you. And then with GMR sensors, I mean, your sensors are much more accurate than Hall sensors. I mean, and we spoke about this at the shareholder meeting. What's the potential over time for NVE spintronic sensors to replace Hall sensors? Dan Baker | President and CEO: Well, we see excellent potential for GMR, which is giant magneto resistance, which is our legacy technology, the technology that the company was really founded on. But we still sell a lot of those sensors. They're still best in class. And Hall effect sensors, as you know, are semiconductor type sensors. They are not as precise, as accurate, or as power efficient as our spintronic sensors. So we see excellent opportunities to replace those sensors in many applications. The one area that where we don't try to compete with Hall effect sensors is they can be very inexpensive because it's mature technology. the tooling is probably long since been written off and they can be sold pretty cheap so our goal is not to sell cheap sensors it's to sell the world's best sensors so we do see ample opportunities for spintronic sensors replacing older types of sensors correct thank you and i just want to say good luck with the expansion sounds like you've got the new lease in place and equipment's coming in so Pete Previtt | Shareholder: keep up the good work. Thanks, Dan. Appreciate it. Dan Baker | President and CEO: Well, thank you. We hope if you're, uh, if you're here this year that, uh, we'll have some exciting things to show you. Pete Previtt | Shareholder: Fantastic. Thank you. Dan Baker | President and CEO: Any other questions? You can press star seven from a phone to unmute or unmute from the Chime app or browser. Jeff Bernstein | Analyst: Hey, Dan, it's, uh, it's, it's Jeff Bernstein again. I meant to ask you about, uh, There was a mention of an additional expense in selling and some Dan Baker | President and CEO: increased staff i guess uh can you just give us the lowdown on what you're doing in terms of adding sales folks exactly yes so i'm glad you asked we are doing more direct sales so more trips more trade shows and more marketing so that's newsletters i mentioned in the prepared remarks we design evaluation boards and we almost have a continuous flow of evaluation boards so that our customers can try out our products easily and prove out their designs so we feel that that's important for our sales so we have staff working on that and staff working on vetting and modeling for our customers designs supporting our distributors and getting out and talking to our customers It looks like there are no other questions in the queue. Again, we were pleased to report strong earnings despite challenging conditions. We appreciate your attention and look forward to speaking with you again on our fiscal year-end earnings call in early May. A replay of this call will be available on the investor events page of our website, nve.com, and our YouTube channel. That's youtube.com slash nvecorporation. You may now disconnect. Thank you. jsPDF 3.0.3 D:20260606090321-00'00'

Research summary and source transcript

readyJun 10, 2026

NVE reported a 5% revenue decline in Q2 FY2025 driven by a 14% drop in product sales, partially offset by a 3,950% surge in contract R&D revenue. Gross margin expanded to 86% from 78% due to a favorable shift toward direct sales and a more profitable product mix, while operating and net margins remained strong at 65% and 60% respectively. The company is investing in capacity expansion via wafer-level chip-scale packaging and maintaining a strong balance sheet to support dividends and R&D, though product sales weakness persists due to distributor inventory overhang.

Management knows that the shift toward direct sales is improving gross margin sustainability and that distributor inventory drawdown is underway, which will likely precede a recovery in product sales that the market has not yet priced in. They also have visibility into early-stage customer interest in wafer-level chip-scale packages and progress on defense-related contract R&D that could convert to product sales within 6-24 months, but these developments are not yet reflected in current revenue or guidance.

Product mix shift (direct vs. distributor sales), R&D investment leading to new product launches, and defense-related contract R&D driving technology development and IP growth.

  • Gross margin expansion due to direct sales and product mix
  • Inventory correction in distributor channels
  • Progress on new product development (ALT521-10E sensor)
  • Capital expenditures for in-house wafer-level packaging
  • Defense contract R&D and anti-tamper/unclonable functions business
  • Medical device navigation and sensor applications
  • Detailed discussion of the ALT521-10E Tunneling Magneto-Resistance Rotation Sensor as the 'world's most sensitive device of its type'
  • Enthusiasm about NASA Europa Clipper validation as proof of quality and reliability
  • Emphasis on unique advantages of sensors for medical device navigation and MRI-tolerant applications
  • Optimism about defense-related contract R&D converting to future product sales
  • Positive tone on customer interest in wafer-level chip-scale package prototypes

Management appears direct, credible, and measured in their communication. They acknowledge challenges (e.g., inventory overhang, semiconductor downturn) while highlighting specific strengths (gross margin expansion, new product validation, balance sheet strength). Avoids overpromising on timelines (e.g., defense conversion, CapEx timing) and provides plausible explanations for financial trends without evasiveness.

  • No clear dodged analyst question was detected by the local fallback; manual review should still check whether Q&A answers quantified conversion, margins, and guidance.
  • No clear goalpost move was detected by the local fallback; the main follow-up is whether future quarters keep the same KPIs and conversion targets.

NVE appears to be maintaining or strengthening its competitive position in niche, high-reliability sensor markets, particularly where miniaturization, precision, and radiation tolerance are valued (e.g., medical devices, defense, space). The NASA Europa Clipper endorsement serves as third-party validation of quality. However, the lack of broader market share data or customer concentration details limits a definitive assessment of competitive gains or losses.

  • Q2 FY2025 total revenue: down 5% year-over-year
  • Product sales: down 14% year-over-year
  • Contract R&D revenue: up 3,950% year-over-year
  • Gross margin: 86% (up from 78% in prior year quarter)
  • Operating margin: 65%, Net margin: 60%
  • EPS: $0.83 for Q2 FY2025
  • First six months FY2025 revenue: $13.5 million (down 15% year-over-year)
  • CapEx spent in first half FY2025: $1.13 million of planned $4–5 million over FY2025–2026
  • Distributor inventory drawdown leading to renewed product orders
  • Conversion of defense contract R&D into product sales within 12-18 months
  • Commencement of in-house wafer-level chip-scale package production late FY2025
  • Growth in medical device navigation and MRI-tolerant sensor demand
  • Successful lead conversion from recent trade shows (MD&M, Advanced Manufacturing)
  • Continued weakness in global semiconductor demand affecting product sales
  • Lumpiness and unpredictability of defense contract timing and funding
  • Risk that R&D investments do not translate into commercial product sales
  • Dependence on distributor channel recovery for product revenue growth
  • Execution risk in scaling wafer-level chip-scale packaging capabilities

There is no mention of data center, AI, or related infrastructure exposure in the transcript. The company's focus remains on industrial IoT, electrification, medical devices, defense, and aerospace applications. Any data center impact would be speculative and not supported by management comments.

  • What specific milestones must be met to begin wafer-level chip-scale package production, and what is the expected timeline for volume ramp?
  • How much of the contract R&D backlog is expected to convert to product sales, and over what time horizon?
  • What is the current estimate of distributor inventory levels, and what signals indicate a sustained recovery in distributor orders?
  • What is the attachment rate and revenue potential of the ALT521-10E sensor in target markets (industrial automation, automotive, medical)?
  • How is the company balancing CapEx spending with dividend sustainability, and what is the expected ROI timeline for the new packaging equipment?
  • What portion of revenue is now direct vs. distributor sales, and is the company tracking this ratio internally for margin forecasting?

FY2025 Q2 earnings call transcript

20,400 chars
NASDAQ:NVEC Q2 2025 Earnings Call Transcript Generated on 6/6/2026 Dan Baker | President and CEO: Good afternoon and welcome to the NVE Corporation conference call for the quarter ended September 30th, 2024. I'm Dan Baker, NVE's President and CEO. I'm joined by Controller and Principal Financial Officer, Daniel Nelson. This call is being webcast live via YouTube and Amazon Chime, and it's being recorded. A replay will be available through our website, nve.com, and our YouTube channel, youtube.com slash nvecorporation. All participants are currently in a listen-only mode. After our presentation, there will be a question and answer session. You'll be able to ask a question by pressing star 7 from a phone or clicking raise my hand from the Chime website or app. After my opening comments, Daniel Nelson will present our financial results, I'll cover products and marketing, and we'll open the call to questions. We issued our press release with financial results and filed our quarterly report on Form 10-Q in the past hour following the close of market. Links to the press release and 10-Q are available through the SEC's website, our website, and on X, formerly known as Twitter. please refer to the Safe Harbor Statement on your screen. Comments we may make that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties, including, among others, such factors as uncertainties related to the economic environments and the industries we serve, and risks and uncertainties related to future sales and revenue, as well as the risk factors listed from time to time in our filings with the SEC, including our annual report on Form 10-K for the year ended March 31, 2024. Actual results could differ materially from the information provided and we undertake no obligation to update forward-looking statements we may make. We're pleased to report strong earnings despite continuing challenges in the semiconductor industry. Daniel Nelson will cover the financials. Daniel? Daniel Nelson | Controller and Principal Financial Officer: Thanks, Dan. Total revenue for the quarter ended September 30, 2024 decreased 5% due to a 14% decrease in product sales, partially offset by a 3,950% increase in contract R&D revenue. The decrease in product sales was primarily due to continued inventory gluts, particularly in the distributor channels, driven by weak chip demand and a slow recovery in global manufacturing. Although the semiconductor industry recovery has been slower than most of us in the industry had hoped, we have an optimistic outlook. Our end markets are improving, and we have growth markets in the industrial Internet of Things and electrification. Gross profit increased 5% from the prior year, and gross margin percentage increased to 86% from 78% in the prior year quarter. The increases were due to more profitable product mix and a larger proportion of direct rather than distributor sales. Total expenses increased 55% for the second quarter of fiscal 2025 compared to the second quarter of fiscal 2024, mostly due to a 24% increase in research and development expense and a 31% increase in selling, general, and administrative expense. The increase in research and development expense was due to increased new product development activities. The increase in selling general and administrative expense was primarily due to increased sales and marketing activities. We added sales personnel and increased marketing activities. Then we'll talk about those activities shortly. Interest income for the quarter decreased 9% due to lower interest rate. Our effective tax rate, which is the provision for income taxes as a percentage of income before taxes, increased to 17% for the second quarter of fiscal 2025 compared to 8% for the second quarter of fiscal 2024. The lower tax rate last year was due to a recovery of credit losses and changes in the timing and amounts of federal tax credits and deductions. The 15% decrease in net income in the second quarter of fiscal 2025 compared to the prior year quarter was primarily due to decreased revenue, increased R&D, increased SG&A, decreased interest income, and a higher tax rate partially offset by increased gross profit margin. With an unrealized gain from marketable securities, comprehensive income increased to $4.71 million from $4.67 million the prior year quarter. It was a profitable quarter with 86% gross margin, 65% operating margin, 60% net margin, and earnings of $0.83 per share. For the first six months of fiscal 2025, total revenue decreased 15% to $13.5 million from $16 million for the first six months of the prior year. The decrease was due to a 20% decrease in product sales, partially offset by a 457% increase in contract R&D revenue. Net income for the first six months was $8.12 million, a $1.68 per diluted share. from $9.13 million, or $1.89 per share, for the first half of fiscal 2024. Now I'll turn the call back over to Dan Baker to cover the business. Over to you, Dan. Dan Baker | President and CEO: Thanks, Daniel. I'll cover new products, sales and marketing, and CapEx. As Daniel mentioned, we've increased our investment in R&D. We spent 13% of revenue in the past quarter on R&D expense, plus customer-sponsored R&D, which is included in cost of sales. As a result of the efforts of our R&D team, we introduced a significant new product earlier this month, the ALT521-10E Tunneling Magneto-Resistance Rotation Sensor. Its build is the world's most sensitive device of its type, which allows for wide mechanical tolerances. Rotation sensing is ubiquitous. Applications include detecting complex motion in factory automation and automotive systems. The technology is also applicable to medical device navigation. There's more information on our website, and our YouTube channel has a demonstration of the new sensor's extraordinary sensitivity and precision. NVE would like to congratulate NASA on its successful Europa Clipper launch last week. Our robust components are mission-critical parts of the spacecraft's sophisticated instruments that will search Jupiter's icy moon for signs of life. The craft is scheduled to reach Europa in April 2030. NASA rigorously qualified our parts, a great validation of our quality and reliability. As Daniel noted, we've also increased our investment in sales and marketing. We exhibited at the Medical Design and Manufacturing Trade Show last week in Minneapolis, part of the Advanced Manufacturing event. Minnesota's healthcare industry hub and medical devices are an important market for us. We have a convincing benefit proposition for medical devices with small size, low power, and superb reliability. Specifically, we demonstrated our new high-field tunneling magnetoresistance sensors, which have a unique omnidirectional capability and detect high fields so they can detect the high fields from MRI to enable MRI-tolerant medical devices. We also featured our medical device navigation technology and our best-in-class electrical isolators to ensure the safety of medical instruments. Turning to CapEx, we've previously discussed plans for $4 to $5 million in capital investments over the next two fiscal years, fiscal 2025 and 2026. We've already spent $1.13 million in the first half of this fiscal year, fiscal 2025. The investments will increase our capacity and capabilities, including the capability to manufacture wafer-level chip-scale packages in-house. These parts will be smaller, higher performance, and allow us to be more self-sufficient and capture more value. We are developing several wafer-level chip scale part types, we have provided customers with prototypes, and there has been strong customer interest. We hope to begin some production late this fiscal year. We have looked at other buildings in the area as options for the expansion, or we could expand in our current buildings. Our current lease expires in March 2026, and we're exploring a lease extension with an allowance to help pay for an expansion in our current building. We held our annual shareholders meeting in August in person here at NVE. Proxy advisory firms recommend in-person annual meetings for good governance. All of our directors and officers attended, along with our auditors. We had a chance to meet shareholders and answer questions. In the formal meeting, each director was re-elected, including Kelly Way, who was elected for the first time. Named executive officer compensation was approved, and the selection of our independent registered public accounting firm was ratified. Shareholders had a chance to see and try out hands-on product demonstrations and tour our facility. Demonstrations included a hot dog cooker to demonstrate our power conversion products and a chessboard to demonstrate an array of position sensors. There's a replay of the meeting with slides and product demonstrations on our website and YouTube channel. We filed the final vote counts in a current report on Forum 8K. Now we'd like to open the call for questions. To ask a question from a phone, press star 7 to unmute, or from a browser or Chime app, click the Raise My Hand icon under the meeting chat. That's at the bottom of the left column, and unmute yourself to speak. Please state your name and affiliation before your question. And to prevent background noise, please mute your line after asking your question. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Hi, Dan and Dan. It's Jeff Bernstein from Silverberg Bernstein Capital. How are you? Dan Baker | President and CEO: Good. How are you, Jeff? Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Good. Good. I have a couple questions for you. One, you had a big uptick in the R&D, contract R&D. Can you just talk about what that completed project was about? Dan Baker | President and CEO: Yes. So most of our contract R&D is related to defense business and developing new systems, particularly anti-tamper systems. So that's usually the nature of the contract R&D, and our hope is that it will result in product sales, down the road defense product sales. So because of the nature of those types of contracts, we are generally not able to get too specific about them. But the other advantage of those types of contracts is they build our intellectual property portfolio, they expand our technology platform, and our R&D team did a great job on that project. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Gotcha. And so is that something that you think could be a product in the next 12 or 18 months? Dan Baker | President and CEO: it could be it's difficult to to predict time frames they depend on procurement cycles sometimes they take longer than that but uh that's that's the goal is uh that we we typically do r d with with a goal of developing either technology that we can uh turn into products or that it's for a customer that will buy a custom high value added product Jeff Bernstein | Analyst at Silverberg Bernstein Capital: I understand. Okay. And then the unclonable functions business has been volatile over time. Can you just give us an update there? Seems like we're sending a lot more sophisticated systems overseas these days and that at some point that ought to convert into some positive momentum. Dan Baker | President and CEO: It does, Jeff. As you say, defense systems that are sold to allies often need anti-tamper protection. They're especially susceptible to falling into unfriendly hands. So while we hate to see some of the conflicts and instabilities, So allied weapon sales and defense system sales do tend to help that business. And as you know, there was recent earlier this year, there was an appropriation for allies specifically for Taiwan, Ukraine, and Israel. So those types of systems tend to require anti-tamper. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Okay, and was it kind of a low quarter on unclonable functions this quarter, or has this business been strong? Dan Baker | President and CEO: They were strong in the past quarter, but as you know, the sales can be lumpy and vary from quarter to quarter based on procurement schedules. We're optimistic about the long-term defense sales based on what we see now, but it's hard to predict quarter to quarter. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Gotcha, yeah, and... You did make the comment in the queue and on the call about a mixed shift in revenue more towards direct and less distribution. That had a very nice positive impact on gross margin. And you mentioned that the product revenue weakness was more due to inventory hangover in the distribution channel. and with direct customers. Can you just dive into that a little bit further? Dan Baker | President and CEO: Yes. So the industry is in a slowdown. The semiconductor industry in general is in a slowdown. So when that happens, what tends the distributors tend to build up their inventories because then customers aren't buying them. And then we get what's sometimes called the bullwhip effect. The supply chain amplifies market changes since customers tend to cancel orders to manage inventories during downturns. But the positive was that our end customer sales remained strong, and because we don't have a distributor margin in there, that tends to help our margins. And so as Daniel pointed out in the prepared remarks, our gross profit actually increased in the quarter year over year, even though the revenue was down slightly. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: And can you just give us kind of an order of magnitude, you know, range of sales as a percent to the distribution channel? You know, does it range from, you know, 40 to 50 percent or 10 to 20 percent or, you know, et cetera? And I would assume that so we're in a trough now and we're kind of at the lower end of whatever that range is. Dan Baker | President and CEO: You're exactly right. We certainly hope we're at the lower end and that the inventories in the channel appear to be being depleted, which is a good sign for us because that means that the distributors will tend to return to buying so that they're booked to bill, if you will, that the amount that they're buying is going to more closely correlate to what their customers are buying. We don't report a percentage or a number, but I think qualitatively, you're right. The distributor sales are low right now and user sales have not been as depressed because of the effects that I mentioned. And so we're hopeful that the distributor sales will pick up again and the percentage will increase. Jeff Bernstein | Analyst at Silverberg Bernstein Capital: Okay. And then I wanted to touch on, you had a piece out during the quarter and you touched on this in the call about precise navigation sensors for catheters. Um, and, uh, and we talked about, uh, you and I during the quarter, um, that that was potentially, um, uh, something that was applicable to the new pulse field ablation, uh, catheters out there and, and your biggest customer, uh, is offering one and, um, and it's expected to be a big growth area for them. Uh, looks like, uh, Medtronic where your new director. is also offering the same thing. And they describe theirs as, this is Medtronic, as having real-time local impedance reading to assess catheter proximity to tissue. So I'm assuming that we're kind of talking about the same thing in terms of the navigational capabilities that your parts bring, but can you just discuss that a little bit? Dan Baker | President and CEO: Yeah, so as you point out, that is an important area for us and an area where we have a convincing benefit proposition in that our sensors are smaller and more sensitive than other technologies. So the way our customers can use this is to detect an external magnetic field that's imparted on the catheter, and then they can infer from that the position of the catheter in the body. And that's very important so that they can get the catheter to the right place and deliver the therapy or make sure that it's in the right blood vessel in the case of things like coronary cancer. angioplasty catheters. So it's an area that's becoming more important and where precision and small size is becoming more important. So our sensors have unique advantages in that area. And that was one of the things that we were promoting at the recent MD&M conference that we talked about in the prepared remarks. Gotcha. I understand. Thank you. Thank you, Jeff. Mike Osterman | Investor: This is Mike Osterman. Can I ask a question? Dan Baker | President and CEO: Yes, go ahead, sir. Mike Osterman | Investor: Yeah, Dan, this is Mike Osterman. I met you a couple of years ago at the annual meeting. Oh, yes, of course. Yes, two questions. First of all, I know you finished up your trade show, all your trade shows. I was just wondering, What the outcome was anything real positive is going to come out of that, and then the second question is since you've increased your capital cap X expenditures is that affecting your cash flow or how is it affecting your cash flow in relation to the dividend. Dan Baker | President and CEO: All right, so with regard to the first question, trade shows, we were pleased with the response, the traffic, and the leads that we got at the trade shows. We recently did a wrap-up video. It's on YouTube if you're interested. But we had three major trade shows during the season. And the last one was MD&M, which was last week. And we have a lot of leads to follow up. So our sales and sales support staff are working on that. And we're working on with the customers and with our distributors to follow up on some of the leads that we got at shows and at trips that were associated with those shows. So, we're pleased with that. Sometimes there's obviously a lag there and it takes some time to develop these leads, but we're optimistic that these will turn into business and into sales. In terms of the capital expenditures and cash flow, so the cash flow tends to lead the capital expenditure. We often make down payments, so much of the $1.1 million that we mentioned that we've spent so far in CapEx this fiscal year, the first half of the fiscal year, is down payments on equipment, so the equipment will be delivered Subsequently, but in the meantime, we have to pay cash for it to get the equipment going because these are custom pieces of equipment that are being designed to our specifications. The hope, of course, is that they will be able to generate products and business and will have a good return on the investment. But in the meantime, we're spending money that we believe is an investment. We believe though that we have a strong balance sheet and that we can continue to have both an aggressive dividend to build our shareholder value and the investments in capital expenditures, sales and marketing, and R&D that will pay off in the future. Mike Osterman | Investor: Okay, because your balance sheet, the cash balance, has come down as you've been making these forward payments for equipment, correct? Correct. Dan Baker | President and CEO: It has, yes. But we still have, by most metrics, a very strong balance sheet. We can support a dividend, and we can continue to make the investments we need to make. Mike Osterman | Investor: Okay. And this equipment hopefully comes online. Did you just have a time frame? Did I may have missed the timing that you said? Dan Baker | President and CEO: This fiscal year and next fiscal year. So that's fiscal 2025 and 2026. However, we do hope to be in some production of some of the new products that are related to the investments this fiscal year, which would end March 31st, 2025. Okay. Okay. Mike Osterman | Investor: Thank you. Dan Baker | President and CEO: Are there any other questions? You can unmute your microphone. Well, if not, we were pleased to report strong earnings for the past quarter and increases in gross profit and comprehensive income as the industry continues to recover. We look forward to speaking with you again on our next earnings call in January. A replay of this call will be available on the investor events page of our website, NVE.com, and our YouTube channel. That's YouTube.com slash NVE Corporation. Thank you for participating in today's call. jsPDF 3.0.3 D:20260606090322-00'00'